Serum biomarkers linking IBD to neurodegeneration include elevated neurofilament light chain (NfL), neuron-specific enolase (NSE), and inflammatory cytokines such as IL-6 and TNF-α. Here, ENO2 is linked to inflammatory bowel disease.